3 Beaten-Down Stocks That Could Soar This Year
You've probably heard the old saying, "The bigger they are, the harder they fall." That might be true, but when it comes to investing, smaller stocks can fall pretty hard as well. The best of them, though, don't stay down indefinitely.
Three Fool.com contributors have identified beaten-down stocks of relatively small companies that could soar this year. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Exelixis (NASDAQ: EXEL), and Intellia Therapeutics (NASDAQ: NTLA).
Prosper Junior Bakiny (CRISPR Therapeutics): Unprofitable clinical-stage biotech companies got hammered last year. Gene-editing specialist CRISPR Therapeutics fits that description to a T, so it got dragged down along with the broader market. The company's shares are down by nearly 25% over the last 12 months. But 2023 could prove to be a turning point.
Source Fool.com
